Newsletter | May 4, 2026

05.04.26 -- Kodak Flips The Script To Biopharma Manufacturing In Rochester

SPONSOR

Join Outsourced Pharm Live’s Jeff Buguliskis and panelists on May 11 at 11 AM ET for ADC Outsourcing: Plan Smart Now or Suffer LaterRegistration for this virtual event is free thanks to sponsor Lonza.

INDUSTRY INSIGHTS

How Asia And Europe Are Reshaping Biologics Manufacturing

As biologics manufacturing globalizes, companies must balance cost, capacity, risk, and control when choosing between European and Asian supply bases for clinical and commercial success.

The Bispecific Antibody Boom Has A Manufacturing Fix

Advanced cell line strategies improve stability and chain pairing while accelerating production, helping developers overcome scalability, productivity, and timeline challenges.

Why The Right Partner Matters In mAb Manufacturing

Early collaboration with an expert partner streamlines HME projects through optimized formulation, strong scale‑up, solid analytics, and adaptable technologies that boost performance.

FEATURED EDITORIAL

Kodak Flips The Script To Biopharma Manufacturing In Rochester

Well, that didn’t work out as planned, writes Chief Editor Louis Garguilo, referring to Kodak's plan in 2018 to revitalize the Eastman Business Park in Rochester, NY. The incoming chairman and now CEO, Jim Continenza, didn’t like that movie, and flipped the script. Instead, Kodak has, so to speak, returned to itself – back to a domestic specialty materials and chemicals supplier, intent on serving biopharma in that capacity.

FDA's First cGMP Enforcement Action On AI Misuse In Drug Manufacturing

The warning letter, issued to Purolea Cosmetics Lab, describes a manufacturer that used AI agents to generate drug product specifications and more. Here's why the outsourced pharma industry should take note.

INDUSTRY INSIGHTS CONTINUED

Scaling Manufacturing Flexibility For Fill-Finish Commercial Success

Pharma and biotech developers rely on adaptable fill‑finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.

A Guide To Scale-Up And Purification For Small, Large Molecules

Advance your separation and purification strategies by leveraging modern industrial chromatography approaches that scale reliably from lab to production across small-molecule and biologics.

Improvements In ADC Efficacy And Stability

Antibody–drug conjugates link antibodies to potent toxins, but increased hydrophobicity impairs stability, manufacturing, and PK, spurring interest in hydrophilic linker strategies.

DVT: A New Paradigm For Life Sciences Validation

Digital validation tools help teams cut cycle times, reduce labor hours, and strengthen compliance. Learn more about measurable efficiency gains and steps for adopting a digital validation approach.

Optimizing Syringe Performance For Reliable Drug Delivery

Reliable drug delivery requires precision. Maintaining a robust seal throughout a product’s shelf life is essential to preserve sterility and ensure patient safety during self-administration.

The Hidden Challenges Of ADC Manufacturing - And How To Overcome Them

ADC manufacturing requires specialized expertise, single‑use systems, precise filtration, aseptic filling, and integrated lyophilization to ensure stability, safety, and consistent clinical‑grade production.

Unlock Robust And Reliable Stability Data With The Right Partner

Stability testing is essential to ensuring your drug’s stability, potency, efficacy, and safety under different controlled conditions throughout development, manufacturing, and life cycle management.

Leading Initiatives That Align Technology, Systems, And Processes

Uncover the strategy for achieving sustainable growth through organizational transformation. Systematic digitization and right-sized automation set the stage for next-level operational excellence.

Formulation Development Of Enterically Protected Spray Dried Dispersions

Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

Set Up And Qualify GMP Laboratories

See how a GMP microbiology lab was established and qualified in Ireland, providing expertise, staffing, training, and project management to ensure compliant operations and client success.

From Bottlenecks To Breakthroughs: Mastering Buffer Management

Traditional process liquid and buffer manufacturing has been shown to be resource-intensive. Watch to explore strategies to overcome buffer-related bottlenecks in large-scale biomanufacturing.

A Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells

When choosing between protein expression formats such as transient versus stable pools, considerations include speed, cost, titre, and product quality.

SPONSOR

Pharma and biopharma companies face urgent pressure to regionalize supply chains amid geopolitical and regulatory volatility. Join us on May 6th for a virtual event hosted by Outsourced Pharma & Orientation Marketing, featuring top CDMO CEOs and experts discussing multi-billion-dollar investments in U.S. and European capacity, strategies for mitigating geographic risk, and actionable insights on CDMO partnerships to ensure supply continuity, regulatory compliance, and scalable, flexible manufacturing in a rapidly changing global market.

SOLUTIONS

Raising The Bar For Large‑Molecule Drug Development

Flow Solutions For Pharmaceutical Manufacturing

From Lab Through Launch

From Vision To Vial

pDNA Manufacturing

Integrated ADC Offering: From Concept To Commercialization

Leveraging Advanced Technology And Proven Expertise

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: